Boston Therapeutics expands Asian markets for Sugardown ingredient as company scrambles to raise capital
Boston Therapeutics Inc. has announced a new marketing deal for its recently-launched Sugardown blood sugar management ingredient that will expand the potential distribution in Asia. The deal comes at an opportune time as the company is scrambling to...